Content about Anatomy

October 9, 2012

Depilatories are experiencing double-digit growth, according to 52-week data ended Sept. 9 from SymphonyIRI Group, and Nad’s is looking to snap up some sales with its new Nose Wax for men and women.

GARDEN GROVE, Calif. — Depilatories are experiencing double-digit growth, according to 52-week data ended Sept. 9 from SymphonyIRI Group, and Nad’s is looking to snap up some sales with its new Nose Wax for men and women. The DIY wax system is positioned as the world’s first nose wax. It is applied with a special Safetip applicator that is designed to target the hair around the edge of the nostril. Each package of Nad’s Nose Wax contains three treatment packs, a “moustache stencil” for men, post-wax calming wipes and antibacterial wipes.

October 9, 2012

Nail polish continues to be the rock star of the beauty world, and it shows no signs of slowing. A recent report by Packaged Facts, titled “The Nail Care Market in the U.S.,” addresses the robust growth of the nail care market and suggests “several intertwined factors are driving 
the market.”


Nail polish continues to be the rock star of the beauty world, and it shows no signs of slowing. A recent report by Packaged Facts, titled “The Nail Care Market in the U.S.,” addresses the robust growth of the nail care market and suggests “several intertwined factors are driving 
the market.”


October 3, 2012

A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

INDIANAPOLIS — A drug marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly reduced blood sugar in elderly patients with Type 2 diabetes and in adults with diabetic nephropathy, according to results of three studies presented at a diabetes meeting in Berlin.

October 1, 2012

Reckitt Benckiser recently named Tiffany McLaud to the position of consumer healthcare marketing director.

PARSIPPANY, N.J. — Reckitt Benckiser recently named Tiffany McLaud to the position of consumer healthcare marketing director. McLaud joins RB from Pfizer Consumer Healthcare where she held a number of senior positions, most recently as senior director of U.S. dietary supplements.

As RB's healthcare marketing director, McLaud will oversee the company's healthcare portfolio, including Mucinex, Delsym and Cepacol.

September 21, 2012

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

The biotech manufacturer announced the FDA approval of Prolia (denosumab) to increase bone mass in men with osteoporosis who are at high risk for fracture. The drug already was approved for osteoporosis in postmenopausal women.

September 19, 2012

Helen of Troy has announced the availability of Beauty Chic, a new line of home spa products for feet, face and skin.

EL PASO, Texas — Helen of Troy has announced the availability of Beauty Chic, a new line of home spa products for feet, face and skin.

The Beauty Chic line consists of a manicure and pedicure kit, nail dryer, facial sauna, foot bath massager, paraffin bath, bath spa kit and a facial spa kit. All of the spa products were designed to give women the same results they would receive in a salon.

September 18, 2012

Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow.

LOS ANGELES — Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow. According to one study, about half of all seniors suffer from leg cramps — they’re more common in women (56%) than men (40%). And two drug classes with strong links to leg cramps include diuretics and the inhaled long-acting B2-agonists 
(e.g., Advair, Serevent, Symbicort).

September 18, 2012

L’Oréal Paris is looking to make the hair color aisle at mass easier to shop and is eliminating the guesswork out of choosing the right hair color shade with its new “My L’Oréal Colorist” mobile app, which serves as a personal color consultant.


NEW YORK — L’Oréal Paris is looking to make the hair color aisle at mass easier to shop and is eliminating the guesswork out of choosing the right hair color shade with its new “My L’Oréal Colorist” mobile app, which serves as a personal color consultant.


September 13, 2012

Hair removal brand Nad's has announced the launch of Nad's nose wax for men and women, a complete do-it-yourself nose wax system for removing nose hair.

LOS ANGELES — Hair removal brand Nad's has announced the launch of Nad's nose wax for men and women, a complete do-it-yourself nose wax system for removing nose hair.

Containing chamomile and aloe, Nad’s nose wax is applied with the Nad’s Safetip applicator that is designed to target the hair around the edge of the nostril, only removing hairs that are sticking out or easily noticed. The specially formulated wax also can be used to remove blackheads from the nose’s surface.

September 12, 2012

After three years in development, HeadBlade is introducing its most innovative design since the original HeadBlade Classic in 1999. Enter the HeadBlade ATX All Terrain Razor.

NEW YORK — After three years in development, HeadBlade is introducing its most innovative design since the original HeadBlade Classic in 1999. Enter the HeadBlade ATX All Terrain Razor.

The new HeadBlade ATX All Terrain Razor is now available online and will hit retail stores in early 2013. The manufacturer's suggested retail price for ATX is $15 at headblade.com; the manufacturer's suggested retail price for HB4 Blade Refills is $11.97 at headblade.com.

September 4, 2012

According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system), as submitted by MSD Consumer.

SILVER SPRING, Md. — According to a Food and Drug Administration post Friday, the FDA's Nonprescription Drugs Advisory Committee will be meeting Nov. 9 regarding the partial switch application from prescription to over the counter of Oxytrol (oxybutynin transdermal system) submitted by MSD Consumer. The proposed OTC product would be called Oxytrol for Women and would be indicated for the treatment of overactive bladder in women.

The prescription form of Oxytrol is licensed by Watson Pharma.

September 4, 2012

Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

HAYWARD, Calif. — Generic drug maker Impax Labs has settled with a subsidiary of Sanofi regarding generic versions of two drugs for dialysis patients, Impax said Tuesday.

Impax announced a settlement with Genzyme concerning generic versions of Renvela (sevelamer carbonate) 800 mg tablets and 2.4 g and 0.8 g oral suspension and Renagel (sevelamer hydrochloride) tablets in the 400 mg and 800 mg strengths.

September 4, 2012

Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

INDIANPOLIS — Lilly Diabetes announced that it has launched a new mobile application designed for caregivers and healthcare providers who support people with Type 1 diabetes.

The Lilly Glucagon mobile app is an interactive tool designed to teach caregivers how to use severe hypoglycemia treatment Glucagon (1-mg) for injection through simulated practice, thus helping caregivers better understand Glucagon's role in diabetes management. The Lilly Glucagon mobile app includes:

  • Information about severe hypoglycemia and Glucagon;

August 30, 2012

Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.

DALLAS — Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, according to a multicenter study published in Tuesday's issue of the Journal of Clinical Oncology.

August 29, 2012

A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

WASHINGTON — A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

According to published reports, the panel voted 15-2 that the benefits of Humira outweighed the risks in treating ulcerative colitis. However, the panel asked Abbott to conduct more studies upon Humira's approval.

August 23, 2012

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

SPRING HOUSE, Pa. — A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

August 15, 2012

The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for enlarged prostate made by generic drug maker Wockhardt, the company said.

Wockhardt, based in Mumbai, India, announced the approval of alfuzosin hydrochloride extended-release tablets in the 10-mg strength, which is designed to treat enlarged prostate, also known as benign prostatic hyperplasia.

The drug is a generic version of Sanofi's Uroxatral. Various versions of the drug have sales of about $81.5 million, according to IMS Health.

August 14, 2012

Target’s in-store health clinics recently started offering consultations for eyelash lengthening and the treatment of hyperpigmentation of the skin and unwanted facial hair, according to a local news report.

MINNEAPOLIS — Target’s in-store health clinics recently started offering consultations for eyelash lengthening and the treatment of hyperpigmentation of the skin and unwanted facial hair, according to a local news report.

July 31, 2012

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

According to the American Heart Association, 1-out-of-3 American adults has high blood pressure or hypertension. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure and kidney failure.

June 28, 2012

The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.

The FDA announced the approval of Myrbetriq (mirabegron), which works by relaxing the bladder muscle while the organ is filling. In patients with overactive bladder, the muscle can't be controlled, squeezes too often or squeezes without warning. Symptoms of overactive bladder include the need to urinate too often, the need to urinate immediately and incontinence. The condition affects about 33 million Americans.

June 21, 2012

False lashes a faux pas? No way! Thanks in large part to celebrities who have popularized false eyelashes and lash extensions, sales of false lashes have been, and continue to be, on the upswing — in a big way.


False lashes a faux pas? No way! Thanks in large part to celebrities who have popularized false eyelashes and lash extensions, sales of false lashes have been, and continue to be, on the upswing — in a big way.


Pacific World, which currently markets Revlon-branded false lashes, is looking to bring its Eyelene lash brand to the U.S. market in 2013. Eyelene currently is sold in the United Kingdom and Canada.


June 13, 2012

Ed Randall's Fans for the Cure on Wednesday announced that it once again has teamed with Walgreens to increase awareness about prostate cancer in baseball ballparks across the United States.

NEW YORK — Ed Randall's Fans for the Cure on Wednesday announced that it once again has teamed with Walgreens to increase awareness about prostate cancer in baseball ballparks across the United States. For the second year, Fans for the Cure and Walgreens are sponsoring a Baseball Road Trip, designed to strike out prostate cancer by encouraging men to "visit your doctor to check for prostate cancer, get your PSA score and stay in the game."

The road trips kicks off on Father's Day, June 17.

February 22, 2012

Mode beauty brand, which was developed by second-generation cosmetics purveyors Cristina Samuels and Jennifer Isaac, has created the new Natural Skin High Performance Hydrating foundation.

ALBANY, N.Y. — Mode beauty brand, which was developed by second-generation cosmetics purveyors Cristina Samuels and Jennifer Isaac, has created the new Natural Skin High Performance Hydrating foundation.

February 8, 2012

While many men report using some sort of grooming product, there still is a significant opportunity in facial skin care for men, according to a new study by market research firm NPD Group.

PORT WASHINGTON, N.Y.  — While many men report using some sort of grooming product, there still is a significant opportunity in facial skin care for men, according to a new study by market research firm NPD Group.

February 8, 2012

Takeda Pharmaceutical has launched a drug for treating high blood pressure in adults, the company said.

DEERFIELD, Ill. — Takeda Pharmaceutical has launched a drug for treating high blood pressure in adults, the company said.

Takeda announced the availability of Edarbyclor (azilsartan medoxomil and chlorthalidone), a once-daily tablet for the condition, also known as hypertension.